Laura T. Pizzi, PharmD, MPH

Contact Dr. Pizzi

130 South 9th Street
Suite 1540F
Philadelphia, PA 19107

(215) 955-1159
(215) 503-9052 fax

Education
PharmD, Rutgers University College of Pharmacy
MPH, University of Medicine and Dentistry of New Jersey

University Appointment
Associate Professor of Pharmacy Practice
Research Associate Professor of Health Policy, Jefferson Medical College

Publications

Most recent Peer-reviewed Publications

1. Cost effectiveness of a home-based intervention that helps functionally vulnerable older adults age in place at home
2. Comparison of three societally derived health-state classification values among older African Americans with depressive symptoms
3. Payer decision-making with limited comparative and cost effectiveness data: The case of new pharmacological treatments for gout
4. Erratum: Impact of transdermal oxybutynin on work productivity in patients with overactive bladder: Results from the MATRIX study (Pharmacoeconomics (2009) 27:4 (329-39)
5. Costs of early adjuvant radiation therapy after radical prostatectomy: A decision analysis
6. A community-integrated home based depression intervention for older African Americans: Descripton of the Beat the Blues randomized trial and intervention costs
7. Physician beliefs and practices for adjuvant and salvage radiation therapy after prostatectomy
8. Comparative effectiveness research for prostate cancer radiation therapy: Current status and future directions
9. Costs to hospitals of acquiring and processing blood in the US: A survey of hospital-based blood banks and transfusion services
10. Diabetes quality measurement: A primer for pharmacists
11. Use of Problem-Based Learning to Develop Physicians' Comparative Effectiveness Interpretive Skills: Experiences From a Workshop Featuring the ICER Report on Management Options for Low-Risk Prostate Cancer
12. Economic impact of prior authorization policies for atypical antipsychotics in the treatment of schizophrenia
13. Evaluating willingness-to-pay thresholds for dementia caregiving interventions: Application to the tailored activity program
14. Reflections on cost and outcomes in facial plastic surgery: Five reasons to measure value
15. FILLERS-Q: An instrument for assessing patient experiences after treatment with facial injectable soft tissue fillers
16. The cost-effectiveness of a nonpharmacologic intervention for individuals with dementia and family caregivers: The tailored activity program
17. Impact of transdermal oxybutynin on work productivity in patients with overactive bladder: Results from the MATRIX study
18. Economic Considerations in a Changing Anemia Environment
19. Ferric gluconate treatment provides cost savings in patients with high ferritin and low transferrin saturation
20. Pharmacoeconomics is coming of age

View All Publications